β³ Fetching live dividend data...
Home βΊ Calculator βΊ EKTAY Dividend Calculator 2026
Elekta AB (publ) Β· OTC
Price: $5.93 Β· Annual div: $0.2536/share Β· Frequency: semi-annual Β· Payout ratio: N/A Β· Ex-div: 2026-09-04
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
| Ex-Dividend Date | Payment Date | Amount / Share | TTM Yield | Stock Price |
|---|---|---|---|---|
| 2026-09-04Latest | 2026-09-30 | $0.1236 | 6.97% | $5.48 |
| 2026-03-06 | 2026-03-26 | $0.1299 | 6.08% | $6.20 |
| 2025-09-08 | 2025-09-26 | $0.1286 | 7.54% | $4.82 |
| 2025-03-07 | 2025-03-27 | $0.1187 | 4.24% | $5.54 |
| 2024-09-09 | 2024-09-27 | $0.1160 | 3.61% | $6.42 |
| 2024-02-26 | 2024-03-18 | $0.1157 | 2.99% | $7.53 |
| 2023-08-25 | 2023-09-15 | $0.1094 | 4.20% | $7.97 |
| 2023-02-24 | 2023-03-17 | $0.1137 | 4.56% | $7.40 |
| 2022-08-26 | 2022-09-16 | $0.1114 | 3.21% | $6.96 |
| 2022-02-25 | 2022-03-18 | $0.1122 | 3.34% | $10.36 |
| 2021-08-26 | 2021-09-16 | $0.1275 | 2.27% | $14.89 |
| 2021-04-19 | 2021-05-10 | $0.1068 | 1.61% | $13.08 |
| 2020-08-27 | 2020-09-17 | $0.1032 | β | β |
| 2020-02-21 | 2020-03-13 | $0.0933 | β | β |
| 2019-08-23 | 2019-09-13 | $0.0923 | β | β |
| 2019-03-01 | 2019-03-22 | $0.0745 | β | β |
| 2018-08-30 | 2018-09-21 | $0.0769 | β | β |
| 2018-02-22 | 2018-03-15 | $0.0603 | β | β |
| 2017-08-23 | 2017-09-14 | $0.0626 | β | β |
| 2017-03-02 | 2017-03-24 | $0.0276 | β | β |
| 2016-08-31 | 2016-09-23 | $0.0295 | β | β |
| 2015-09-01 | 2015-09-23 | $0.0592 | β | β |
| 2014-08-28 | 2014-09-22 | $0.2821 | β | β |
| 2013-09-04 | 2013-09-26 | $0.3054 | β | β |
| 2012-09-05 | 2012-09-27 | $0.7558 | β | β |
| 2012-05-03 | 2012-05-17 | $0.2298 | β | β |
| 2011-09-14 | 2011-10-06 | $0.5959 | β | β |
| 2009-09-16 | 2009-10-08 | $0.2928 | β | β |
Elekta AB (publ) is a global medical technology company dedicated to developing and delivering advanced clinical solutions for the treatment of cancer and brain disorders. Its comprehensive portfolio includes innovative radiotherapy systems such as the Elekta Unity MR-Linac, the Elekta Harmony linear accelerator, Elekta Infinity for diverse patient radiotherapy requirements, and the Elekta Synergy digital accelerator for advanced image-guided radiation therapy. Specific solutions like Versa HD are available for managing brain metastases. The company also supplies crucial treatment management software, automated and integrated quality assurance tools, and hardware and software for motion management. Further augmenting its oncology offerings, Elekta provides MOSAIQ Plaza for integrated multidisciplinary cancer care and Elekta Axis Cloud for managed hosting. Within brachytherapy, key products include the image-guided Elekta Studio, the mobile ImagingRing CT scanner, Oncentra Brachy for streamlining repetitive tasks, the Elekta Flexitron afterloader for precise workflow execution, and specialized applicators like Venezia and Geneva for cervical cancer treatment. For neurological conditions, Elekta offers a suite of advanced radiosurgery and neurosurgery solutions. This includes the Leksell Gamma Knife series β Icon for personalized radiation treatment, Perfexion for neurosurgical applications, and Lightning for accelerated procedures. Its neurosurgery product line features the Leksell Vantage Stereotactic System for intracranial interventions and the Leksell Stereotactic System for minimally invasive stereotactic neurosurgery. Founded in 1972, Elekta maintains its corporate headquarters in Stockholm, Sweden.
Forward dividend yield from the latest data Β· open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. Β· Privacy Policy
Ready to invest? Open EKTAY position with:
Real after-tax yield depends on where you live and how you hold EKTAY.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| πΊπΈ Roth IRA / 401k | 0% | 4.28% | 1.48% | $428 / yr |
| πΊπΈ US Taxable (15%) β | 15% | 3.64% | 0.84% | $364 / yr |
| πΊπΈ US Taxable (20%) | 20% | 3.42% | 0.62% | $342 / yr |
| π¬π§ UK ISA | 0% | 4.28% | 1.48% | $428 / yr |
| π¬π§ UK Taxable | 8.75% | 3.91% | 1.11% | $391 / yr |
| π¨π¦ TFSA | 0% | 4.28% | 1.48% | $428 / yr |
| π¨π¦ CA Taxable | 25% | 3.21% | 0.41% | $321 / yr |
| π¦πΊ Super (pension) | 15% | 3.64% | 0.84% | $364 / yr |
| π¦πΊ AU Taxable | 30% | 3.00% | 0.20% | $300 / yr |
| π©πͺ DE Taxable | 26.375% | 3.15% | 0.35% | $315 / yr |
| π«π· FR Taxable | 30% | 3.00% | 0.20% | $300 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.25/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
EKTAY pays quarterly β 4 times per year. Ex-div: 2026-09-04.
How EKTAY compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for EKTAY sourced from FMP /financial-growth endpoint β real data, not estimates.
Compare EKTAY with peers: EKTAY vs ARSUF Β· EKTAY vs BOEUF Β· EKTAY vs EBOSY
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores β lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the EKTAY dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β
Elekta AB (publ) (EKTAY) is currently trading at $5.93, 14% below its 52-week high. The current dividend yield is 4.28% based on an annual payout of $0.2536 per share.
Elekta AB (publ) (EKTAY) is a healthcare stock currently trading at $5.93 with a dividend yield of 4.28%. It pays an annual dividend of $0.2536 per share. Over the past 5 years, EKTAY has grown its dividend at a compound annual rate of 5.4%.
Auto-generated from live market data. For educational purposes only β not financial advice.
Illustrative examples of common use cases, written by the DividendFlow team β not customer reviews.
EKTAY (Elekta AB (publ)) has a dividend yield of 4.28%, based on an annual dividend of $0.2536 per share and a price of $5.93. Over the last 12 months it paid $0.2536 per share β a trailing yield of 4.28%. Dividends are paid semi-annual.
Yield history: over the last 12 payments, EKTAY's 12-month yield ranged from 1.61% to 7.54%. Full EKTAY dividend history β
Yield on cost: if EKTAY's dividend keeps growing 5.5% a year, a purchase at today's price would yield 5.59% after 5 years, 7.30% after 10 years and 12.48% after 20 years on the original investment.
With dividends reinvested, a EKTAY position grows its share count by about 4.36% in the first year at today's price and yield. If the dividend grows 5.5% a year and the price 3.5%, DRIP doubles your number of shares in about 15 years without adding new money.
| Year | Shares bought by dividends | Total shares | Dividend income | Position value | Yield on cost |
|---|---|---|---|---|---|
| 1 | 73.51 | 1759.85 | $451 | $10,801 | 4.51% |
| 3 | 83.25 | 1921.30 | $547 | $12,632 | 5.47% |
| 5 | 94.59 | 2104.59 | $666 | $14,823 | 6.66% |
| 10 | 132.16 | 2684.25 | $1,106 | $22,453 | 11.06% |
| 20 | 277.35 | 4700.11 | $3,273 | $55,459 | 32.73% |
DRIP rate = share-count growth from reinvested dividends. Simplified yearly model before taxes and fees; adjust every assumption in the calculator above. Not financial advice. How DRIP and the DRIP rate work β
EKTAY (Elekta AB (publ)) has a dividend yield of 4.28%, based on an annual dividend of $0.2536 per share and a price of $5.93. Over the last 12 months it paid $0.2536 per share β a trailing yield of 4.28%. Dividends are paid semi-annual.
$10,000 in EKTAY at a 4.28% yield pays about $428 a year ($36 a month) before taxes. With DRIP, reinvested dividends buy more shares and that income compounds.
With dividends reinvested, a EKTAY position grows its share count by about 4.36% in the first year at today's price and yield. If the dividend grows 5.5% a year and the price 3.5%, DRIP doubles your number of shares in about 15 years without adding new money.
Enter your starting amount, monthly contribution and time horizon in the EKTAY DRIP calculator at the top of this page. It reinvests each payout into new shares at the projected price, grows the dividend at the rate you choose and shows yearly income, share count, portfolio value and yield on cost. You can switch DRIP off to compare.
EKTAY's next ex-dividend date has not been announced yet; the most recent one was 2026-09-04. EKTAY pays dividends semi-annual. Buy before the ex-dividend date to receive the next payment.
EKTAY's dividend changed 2.5% over the last year and 5.4% a year on average over five years.
News aggregated from public sources via Finnhub & RSS. For informational purposes only.
Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.
I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly β $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.
Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.
As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.
The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.
For educational purposes only. Not financial advice.
Share your real experience on Trustpilot βIf DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
β±οΈ Takes 30 seconds Β· No signup Β· Free forever